JBI CME Vol 7 Issue 5 - Solitary Dilated Ducts 2.0 – Multimodality Img Detection, Assessment, Mgmt
e-Learning
Article: Solitary Dilated Ducts 2.0 – Multimodality Imaging Detection, Assessment, and Management
Learning Objectives:
- Identify and characterize solitary dilated ducts across multiple imaging modalities to improve detection accuracy.
- Differentiate between benign and potentially malignant solitary dilated ducts using specific imaging criteria such as intraductal contents, vascularity, and associated features.
- Apply an evidence-based approach to the management of solitary dilated ducts.
Date(s) of Activity: CE Release Date: June 6, 2025 – CE Expiration Date: June 5, 2028
Joint Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the Society of Breast Imaging. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation Provider Number: 4008163
ACCME Credit Designation Statement: Amedco LLC designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™ for physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Satisfactory Completion: Learners must read the article in its entirety and complete an evaluation form to receive a certificate of completion. The activity must be attended in its entirety as partial credit is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Acknowledgement of Financial Commercial Support: No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support: No in-kind commercial support was received for this educational activity.
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5). All individuals in a position to control the content of CE are listed below.
Tanya Moseley, MD: NA
Natalie Ward: NA
Ryan Dixon: NA